Chae-ok W. Yun
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Oncolytic adenovirus co-expressing IL-12 and shVEGF potentiates immune checkpoint blockade for treatment of renal cell carcinoma: in vitro, organ-on-a-chip, and in vivo evaluation.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 06, 2026
Helical quaternary amine polypeptide programs membrane stress to drive immunogenic cell death and cytosolic gene delivery for cancer immunotherapy.
Journal: Biomaterials
Published: December 17, 2025
Potent therapeutic efficacy of intranasally deliverable paclitaxel modified with pH-sensitive and PEGylated polymeric micelle against glioblastoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 08, 2024
Smart Accumulating Dual-Targeting Lipid Envelopes Equipping Oncolytic Adenovirus for Enhancing Cancer Gene Therapeutic Efficacy.
Journal: ACS nano
Published: October 02, 2024
Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids.
Journal: International journal of molecular sciences
Published: April 15, 2024
Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer.
Journal: Frontiers in immunology
Published: December 23, 2023
Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy.
Journal: Frontiers in immunology
Published: December 14, 2023
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 12, 2023
Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
Journal: The Journal of biological chemistry
Published: November 28, 2023
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
Journal: Cancer letters
Published: August 18, 2023
A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 25, 2023
Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.
Journal: Cell death & disease
Published: June 20, 2023
Last Updated: 09/26/2026